0001209191-17-065094.txt : 20171211 0001209191-17-065094.hdr.sgml : 20171211 20171211183019 ACCESSION NUMBER: 0001209191-17-065094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171211 FILED AS OF DATE: 20171211 DATE AS OF CHANGE: 20171211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 171250604 MAIL ADDRESS: STREET 1: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-11 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001242825 LEIDEN JEFFREY M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 1 0 0 CEO & President Common Stock 2017-12-11 4 S 0 20090 140.31 D 237407 D Common Stock 2017-12-11 4 S 0 87578 141.35 D 149829 D Common Stock 2017-12-11 4 S 0 12134 142.21 D 137695 D Common Stock 2017-12-11 4 S 0 5198 143.39 D 132497 D Common Stock 440 I 401(k) Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $140.31 (range $139.85 to 140.84). Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $141.35 (range $140.86 to $141.85). Open market sales reported on this line occurred at a weighted average price of $142.21 (range $141.86 to $142.79). Open market sales reported on this line occurred at a weighted average price of $143.39 (range $142.90 to $143.85). /s/ Michael LaCascia, Attorney-in-Fact 2017-12-11